David A. Siegel Kodiak Sciences Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q4 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 284,200 shares of KOD stock, worth $1.49 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

284,200

Previous 333,300 14.73%

Holding current value

$1.49 Million

Previous $869,000 225.32%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$2.6 - $10.9 $127,660 - $535,190	-49,100 Reduced 14.73%	284,200 $2.83 Million
Q3 2024 Nov 14, 2024	BUY	$2.2 - $3.25 $72,380 - $106,925	32,900 Added 10.95%	333,300 $869,000
Q2 2024 Aug 14, 2024	SELL	$2.29 - $4.48 $53,128 - $103,936	-23,200 Reduced 7.17%	300,400 $705,000
Q1 2024 May 15, 2024	BUY	$3.01 - $7.45 $53,276 - $131,865	17,700 Added 5.79%	323,600 $1.7 Million
Q4 2023 Feb 14, 2024	BUY	$1.4 - $3.24 $109,060 - $252,396	77,900 Added 34.17%	305,900 $929,000
Q3 2023 Nov 14, 2023	BUY	$1.8 - $7.49 $20,700 - $86,135	11,500 Added 5.31%	228,000 $410,000
Q2 2023 Aug 14, 2023	SELL	$4.3 - $9.48 $221,880 - $489,168	-51,600 Reduced 19.25%	216,500 $1.49 Million
Q1 2023 May 15, 2023	SELL	$4.81 - $8.88 $530,062 - $978,576	-110,200 Reduced 29.13%	268,100 $1.66 Million
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.05 $2.09 Million - $2.58 Million	-320,700 Reduced 45.88%	378,300 $2.71 Million
Q3 2022 Nov 14, 2022	SELL	$7.57 - $12.5 $243,754 - $402,500	-32,200 Reduced 4.4%	699,000 $5.41 Million
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.48 $841,680 - $1.58 Million	-167,000 Reduced 18.59%	731,200 $5.59 Million
Q1 2022 May 16, 2022	BUY	$7.09 - $89.45 $6.13 Million - $77.4 Million	865,100 Added 2613.6%	898,200 $6.93 Million
Q4 2021 Feb 14, 2022	SELL	$80.85 - $128.49 $7.74 Million - $12.3 Million	-95,700 Reduced 74.3%	33,100 $2.81 Million
Q3 2021 Nov 15, 2021	BUY	$81.97 - $106.94 $1.27 Million - $1.66 Million	15,500 Added 13.68%	128,800 $12.4 Million
Q2 2021 Aug 16, 2021	BUY	$77.2 - $126.54 $7.4 Million - $12.1 Million	95,900 Added 551.15%	113,300 $10.5 Million
Q1 2021 May 17, 2021	BUY	$110.45 - $164.47 $110,450 - $164,470	1,000 Added 6.1%	17,400 $1.97 Million
Q4 2020 Feb 16, 2021	SELL	$60.78 - $154.03 $1.35 Million - $3.42 Million	-22,200 Reduced 57.51%	16,400 $2.41 Million
Q3 2020 Nov 16, 2020	BUY	$45.05 - $59.27 $292,825 - $385,255	6,500 Added 20.25%	38,600 $2.29 Million
Q2 2020 Aug 14, 2020	BUY	$42.74 - $66.25 $820,608 - $1.27 Million	19,200 Added 148.84%	32,100 $1.74 Million
Q1 2020 May 15, 2020	BUY	$38.18 - $73.95 $492,522 - $953,955	12,900 New	12,900 $615,000

Others Institutions Holding KOD

# of Institutions

110

Shares Held

40.9M

Call Options Held

13.8K

Put Options Held

5.8K

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $274M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account